期刊文献+

子宫内膜增生合并子宫内膜癌的相关危险因素分析 被引量:7

暂未订购
导出
摘要 目的研究分析子宫内膜增生合并子宫内膜癌的相关危险因素。方法收集60例2015年6月至2016年6月于静宁县中医院妇产科行全子宫切除术,且术前诊断性刮宫(诊刮)提示子宫内膜增生患者的临床资料进行回顾性分析。依据病理类型分为子宫内膜癌组(25例)和子宫内膜增生组(35例),比较两组患者的临床特征和合并子宫内膜癌的相关危险因素。结果 60例患者中41.7%合并子宫内膜癌。单因素和多因素分析结果均提示:年龄≥48岁和诊刮病理为重度子宫内膜不典型增生(重度AEH)为发生子宫内膜癌的危险因素(P<0.05)。不伴任何危险因素、伴有1个危险因素和伴有2个危险因素的子宫内膜增生患者合并子宫内膜癌的概率分别为5.0%、46.2%和81.8%,三者比较,差异有统计学意义(P<0.05),且随危险因素数目的增加,发生子宫内膜癌的风险显著升高(P<0.05)。25例合并子宫内膜癌的患者均为早期子宫内膜样癌。结论子宫内膜增生患者合并子宫内膜癌的发生率较高,特别是高龄(≥48岁)、诊刮病理为重度AEH的患者合并风险显著增加,但合并的子宫内膜癌多为分化较好的早期子宫内膜样癌。
作者 张爱玲
机构地区 静宁县中医院
出处 《卫生职业教育》 2018年第4期149-151,共3页 HEALTH VOCATIONAL EDUCATION
  • 相关文献

参考文献4

二级参考文献42

  • 1郎景和 吴鸣.子宫内膜癌的临床表现与治疗[A].见:连利娟 主编.林巧稚妇科肿瘤学 第3版[C].北京:人民卫生出版社,2000.356-372.
  • 2Lerner JP, Timor-Tritsch IE, Monteagudo A. Use of transvaginal sonography in the evaluation of endometrial hyperplasia and carcinoma. Obstet Gynecol Surv,1999, 51:718-725.
  • 3Goldstein SR, Nachtigall M, Snyder JR, et al. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patient with postmenopausal bleeding. Am J Obstet Gynecol, 1990, 163(1 Pt 1):119-123.
  • 4Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA, 1998, 280:1510-1517.
  • 5Carlson KJ. Vaginal ultrasonography to evaluate postmenopausal bleeding. JAMA, 1998, 280: 1529-1530.
  • 6Goldstein RB, Bree RL, Benson CB, et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med, 2001, 20:1025-1036.
  • 7Sousa R, Silvestre M, Sousa L, et al. Transvaginal ultrasonography and hysteroscopy in postmenopausal bleeding: a prospective study. Acta Obstet Gynecol Scand, 2001, 80:856-862.
  • 8Epstein E, Valentin L. Rebleeding and endometrial growth in women with postmenopausal bleeding and endometrial thickness < 5 mm managed by dilatation and curettage or ultrasound follow-up: a randomized controlled study. Ultrasound Obstet Gynecol , 2001, 18:499-504.
  • 9Maruyama A,Saito T,Hachitanda Y,et al.Cancer history and loss of MSH2and MLH1 protein expression in patients with endometrial hyperplasia.Int J Gynecol Cancer,2003,13(3):352~360.
  • 10Ricci E,Moroni S,Parazzini F,et al.Risk factors for endometrial hyperplasia:results from a case-control study.Int J Gynecol Cancer,2002,12 (3):257~260.

共引文献137

同被引文献50

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部